Codex Capital Asset Management’s Eli Lilly LLY Stock Holding History

Codex Capital Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.8M	Sell	15,655 -2,725	-15%	-$2.78M	6.5%	4
2026 Q1	$16.9M	Hold	18,380	–	–	6.54%	3
2025 Q4	$19.8M	Buy	18,380 +1,380	+8%	+$1.32M	7.18%	2
2025 Q3	$13M	Hold	17,000	–	–	4.88%	6
2025 Q2	$13.3M	Hold	17,000	–	–	5.3%	5
2025 Q1	$14M	Hold	17,000	–	–	6.62%	4
2024 Q4	$13.1M	Hold	17,000	–	–	5.81%	4
2024 Q3	$15.1M	Sell	17,000 -1,000	-6%	-$899K	6.68%	4
2024 Q2	$15.4M	Buy	+18,000	New	+$14.4M	7.05%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Codex Capital Asset Management's LLY Position: Q2 2026 in Review

Codex Capital Asset Management reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $2.78M and leaving 15,655 shares worth $18.8M. The position accounts for 6.5% of the portfolio, ranked #4.

Codex Capital Asset Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.8M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Codex Capital Asset Management held 15,655 shares of Eli Lilly worth $18.8M as of Q2 2026.
Codex Capital Asset Management sold 2,725 Eli Lilly shares in Q2 2026, an estimated $2.78M.
Eli Lilly made up 6.5% of Codex Capital Asset Management's portfolio in Q2 2026, its #4 holding.
Codex Capital Asset Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
Codex Capital Asset Management's Eli Lilly position peaked at $19.8M in Q4 2025.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Codex Capital Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.